Quantitative · filed as “RENAISSANCE TECHNOLOGIES LLC” · CIK 1037389
The information on this page is market data and educational analysis, not financial advice. Past on-chain activity does not guarantee future results. Always do your own research.
Disclosed portfolio
$63.93B
period 2026-03-31
Positions
3,213
distinct issuer/class lines
Filed
2026-05-14
13F-HR — up to 45d after quarter end
Top holdings (25 of 3,213 — % of the full disclosed portfolio)
| # | Issuer | Class | Value | Shares | Weight |
|---|---|---|---|---|---|
| 1 | UNITED THERAPEUTICS CORP DELUTHR | COM | $1.06B | 1,787,019 | 1.7% |
| 2 | PALANTIR TECHNOLOGIES INCPLTR | CL A | $1.02B | 6,985,926 | 1.6% |
| 3 | APPLE INCAAPL | COM | $780.6M | 3,075,638 | 1.2% |
| 4 | KINROSS GOLD CORPKGC | COM | $779.7M | 25,546,413 | 1.2% |
| 5 | MICRON TECHNOLOGY INCMU | COM | $730.7M | 2,162,986 | 1.1% |
| 6 | VERISIGN INCVRSN | COM | $699.9M | 2,818,151 | 1.1% |
| 7 | EXELIXIS INCEXEL | COM | $588.8M | 13,726,993 | 0.9% |
| 8 | FRANCO NEV CORPFNV | COM | $548.2M | 2,218,918 | 0.9% |
| 9 | SANDISK CORPSNDK | COM | $508.0M | 799,568 | 0.8% |
| 10 | NVIDIA CORPORATIONNVDA | COM | $440.7M | 2,526,948 | 0.7% |
| 11 | CHEVRON CORPORATIONCVX | COM | $417.0M | 2,015,396 | 0.7% |
| 12 | ROBLOX CORPRBLX | CL A | $403.1M | 7,126,134 | 0.6% |
| 13 | CARVANA COCVNA | CL A | $377.6M | 1,201,218 | 0.6% |
| 14 | WAYFAIR INCW | CL A | $374.0M | 4,972,425 | 0.6% |
| 15 | ROBINHOOD MKTS INCHOOD | COM CL A | $353.7M | 5,104,137 | 0.6% |
| 16 | INCYTE CORPINCY | COM | $343.7M | 3,651,532 | 0.5% |
| 17 | ARGAN INCAGX | COM | $332.7M | 610,899 | 0.5% |
| 18 | INTEL CORPINTC | COM | $326.5M | 7,399,394 | 0.5% |
| 19 | NEUROCRINE BIOSCIENCES INCNBIX | COM | $318.7M | 2,418,897 | 0.5% |
| 20 | UNITEDHEALTH GROUP INCUNH | COM | $313.5M | 1,158,428 | 0.5% |
| 21 | STERLING INFRASTRUCTURE INCSTRL | COM | $312.3M | 766,914 | 0.5% |
| 22 | LINDE PLC | SHS | $312.2M | 629,820 | 0.5% |
| 23 | WESTERN DIGITAL CORPWDC | COM | $310.0M | 1,146,133 | 0.5% |
| 24 | CBOE GLOBAL MKTS INCCBOE | COM | $309.3M | 1,100,506 | 0.5% |
| 25 | GILEAD SCIENCES INCGILD | COM | $300.0M | 2,152,528 | 0.5% |
As filed with the SEC (original filing). 13F discloses long US equity positions only — no shorts, bonds, cash or non-US holdings — and reflects the position at quarter end, not today. Historical observation, not an endorsement, never advice.